Public trial registry of the CCC-Munich

Trial 26866138-MMY-2045

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
26866138-MMY-2045
World
Full title
:

Eine multizentrische, randomisierte, offene Phase-2-Parallelgruppenstudie zur Bewertung der Sicherheit und Wirksamkeit von VELCADE in Kombination mit Dexamethason oder VELCADE in Kombination mit Dexamethason und Cyclophosphomid oder VELCADE in Kombination mit Dexamethason und Lenalidomid bei Patienten mit multiplem Myelom Refraktär oder nach der Primärtherapie des multiplen Myeloms rezidiviert / fortgeschritten und nach 4 Zyklen VELCADE / Dexamethason-Therapie eine stabile Erkrankung erreicht

World
Description
:
Unknown
Eye
Primary endpoints
:

Eye
Secondary endpoints
:

World
EudraCT number
:
World
DRKS number
:
Unknown
World
NCT number
:
Unknown
World
ISRCTN number
:
Unknown
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Eye
Legal basis
:
Unknown
Eye
Registered by
:
NASSEH-DA ()
Indications
Classification Code Description
ICD-10-GM C90.0- Multiples Myelom
- Bloodcancer (leukemia, lymphoma)
In-/Exclusion (Edit)
Eye
Criterion for Inclusion
:
Unknown
Eye
Criterion for exclusion
:
Unknown
Trial design
World
IIT (sponsored by KUM)
:
No
Eye
Sponsor status
:
Commercial
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Eye
Center design
:
Polycentric
Eye
Treatment arms count
:
Unknown
Eye
Sample size
:
163
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
World
Institutional review board - reference number
:
World
PEI - vote
:
Unknown
World
PEI - reference number
:
World
BfArM - vote
:
Unknown
World
BfArM - reference number
:
Initiiation & lock
World
Date of lock (planned / actual)
:
2011-08-01 / Unknown
Recruitment
Eye
Time period (from / to)
:
Unknown / Unknown
Therapy
World
Therapy line
:
Unknown
Eye
Therapy Category
:
World
Therapy
:

Tumorboards (Edit)
Eye
:
Dermatology Endocrinology Gastrointestinal
Gynecological Hematology KHT
Liver Lung Neurooncological
Pediatry Ortho. / Sarkoma Urological
Additionally involved centers (Edit)
Eye
:
Pharmacy Radiology
Institut für Labormedzin Transfusiology
Radiotherapy Nuclear medicine
Participants
Function Prename Surname Organization
World Principal Investigator HELMUT OSTERMANN Keine Organisationseinheit angegeben Magnifier